华森制药甲磺酸雷沙吉兰片完成境内生产药品备案

Group 1 - The company Huason Pharmaceutical (002907.SZ) has announced that its product, Apsa-Rasagiline Tablets, has completed the domestic production drug filing with the National Medical Products Administration (NMPA) [1] - The filing includes an application for the drug's instructions to be adapted for elderly patients, which indicates a focus on improving accessibility for this demographic [1] - The registration information has been publicly disclosed on the NMPA's website, enhancing transparency regarding the company's product status [1]